NEW YORK (GenomeWeb) – Guardant Health today announced it has raised close to $100 million in the first closing of a Series D funding round.
Combined with earlier funding rounds, the company said the new money brings its total raised to almost $200 million.
Registering provides access to this and other free content.
Already have an account?Login Now.
NPR reports that Turkish high school students will no longer study evolution.
Researchers report they sequenced and identified plant species in an "al fresco" laboratory.
An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.
In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.